The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Twist Bioscience Corp shares valued at $79,774 were sold by Finn Patrick John on Jul 23 ’25. At $35.74 per share, Finn Patrick John sold 2,232 shares. The insider’s holdings dropped to 238,342 shares worth approximately $8.0 million following the completion of this transaction.
Before that, Laponis Adam had sold 2,449 shares from its account. In a trade valued at $93,420, the Chief Financial Officer traded Twist Bioscience Corp shares for $38.15 each. Upon closing the transaction, the insider’s holdings decreased to 2,449 shares, worth approximately $3.48 million.
As published in their initiating research note from Wolfe Research on December 13, 2024, Twist Bioscience Corp [TWST] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 17, 2024, Goldman has increased its “Neutral” rating to a “Buy” for TWST. Earlier on September 27, 2023, Berenberg initiated its rating. Their recommendation was “a Buy” for TWST stock.
Analyzing TWST Stock Performance
On last trading session, Twist Bioscience Corp [NASDAQ: TWST] plunged -3.34% to $33.57. The stock’s lowest price that day was $33.44, but it reached a high of $34.93 in the same session. During the last five days, there has been a drop of approximately -4.30%. Over the course of the year, Twist Bioscience Corp shares have dropped approximately -41.56%.
Support And Resistance Levels for Twist Bioscience Corp (TWST)
RSI (Relative Strength Index) is 41.19 on the 14-day chart, showing neutral technical sentiment.
Is Twist Bioscience Corp subject to short interest?
Stocks of Twist Bioscience Corp saw a sharp rise in short interest on 2025-07-15 jumping by 0.44 million shares to 10.75 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 10.31 million shares. A jump of 4.06% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.98 of the overall float, the days-to-cover ratio (short ratio) jumped to 10.98.
Which companies own the most shares of Twist Bioscience Corp (TWST)?
In terms of Twist Bioscience Corp share price expectations, FactSet research, analysts set an average price target of 50 in the next 12 months, up nearly 43.97% from the previous closing price of $34.73. Analysts anticipate Twist Bioscience Corp stock to reach 58 by 2025, with the lowest price target being 44. In spite of this, 7 analysts ranked Twist Bioscience Corp stock as Buy at the end of 2025. On January 05, 2023, Scotiabank assigned a price target of “a Sector outperform” to the stock and initiated coverage with a $33.
